Financhill
Back

Microsoft Corp. Vs. Akero Therapeutics, Inc. Industry Stock Comparison

Sell
39

MSFT
Microsoft Corp.

Last Price:
$476.25
Seasonality Move:
5.2%
Buy
55

AKRO
Akero Therapeutics, Inc.

Last Price:
$54.65
Seasonality Move:
10.37%
Sell
39
Microsoft Corp. (MSFT) is a Sell

Is Microsoft Corp. a Buy, Sell or Hold?

  • The current Microsoft Corp. [MSFT] share price is $474.82. The Score for MSFT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MSFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Akero Therapeutics, Inc. (AKRO) is a Buy

Is Akero Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MSFT Stock Price Chart

What is Microsoft Corp.'s stock price today?

  • The Microsoft Corp. share price today is $474.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics, Inc.'s stock price today?

  • The Akero Therapeutics, Inc. share price today is $54.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.51 Sell
Relative Strength Index (14 RSI): 39.53 Sell
Chaikin Money Flow: -10417848 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (476.83 - 501.07) Sell
Bollinger Bands (100): (493.01 - 523.77) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 69.15 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.26 - 54.6) Buy
Bollinger Bands (100): (46.52 - 54.32) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 482.8 Sell
20-day SMA: 484.22 Sell
50-day SMA: 503.82 Sell
200-day SMA: 472.29 Buy
8-day EMA: 481.47 Sell
20-day EMA: 486.94 Sell
50-day EMA: 496.79 Sell
200-day EMA: 480.69 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.64 Buy
20-day SMA: 54.48 Buy
50-day SMA: 53.7 Buy
200-day SMA: 48.36 Buy
8-day EMA: 54.62 Buy
20-day EMA: 54.42 Buy
50-day EMA: 53.21 Buy
200-day EMA: 47.82 Buy

Microsoft Corp. Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.81 per share.

Akero Therapeutics, Inc. Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.

Microsoft Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):